Crossmark

Prognostic value of CPSS cytogenetic risk classification in patients with CMML after allogeneic hematopoietic cell transplantation: a retrospective multicenter study of the Chronic Malignancies Working Party of the EBMT

Crossref DOI link: https://doi.org/10.1038/s41409-022-01759-7

Published Online: 2022-07-23

Published Print: 2022-10

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Koenecke, Christian https://orcid.org/0000-0001-7025-1735
Eikema, Dirk-Jan

Hazelaar, Sheree

Schroeder, Thomas

Potter, Victoria

Kröger, Nicolaus https://orcid.org/0000-0001-5103-9966
Bornhäuser, Martin

Finke, Jürgen https://orcid.org/0000-0002-1799-5927
Platzbecker, Uwe

Radujkovic, Aleksandar https://orcid.org/0000-0002-8543-5016
Ganser, Arnold

Salmenniem, Urpu

Blaise, Didier https://orcid.org/0000-0002-5684-9447
Kobbe, Guido

Meijer, Ellen

Friis, Lone

Maertens, Johan

Caballero, Dolores

Cornelissen, Jan J.

Olivieri, Attilio

Gulsum, Ozet

Hayden, Patrick J. https://orcid.org/0000-0003-1374-4503
Onida, Francesco

Robin, Marie https://orcid.org/0000-0003-1388-9876
Yakoub-Agha, Ibrahim https://orcid.org/0000-0003-4524-8782
License Information

Text and Data Mining valid from 2022-07-23

Version of Record valid from 2022-07-23
More Information

Article History

Received: 7 January 2022

Revised: 4 July 2022

Accepted: 6 July 2022

First Online: 23 July 2022

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below